DAB2IP, a novel tumor suppressor, is often downregulated in advanced stages of many types of cancer, and the loss of DAB2IP expression has been shown to correlate with the poor prognosis and increased tumor metastasis of many malignancies7,8. This evidence concerns the gene DAB2IP and cancer.